In re Akebia Therapeutics, Inc., No. 19-1929 (1st Cir. 2020)Annotate this Case
The First Circuit denied the petition for a writ of mandamus filed by Akebia Therapeutics, Inc. pursuant to the Crime Victim's Rights Act, 18 U.S.C. 3771(d)(3), requesting vacatur of the district court's restitution order, holding that the district court properly determined the award of restitution to Akebia, a corporate victim of a securities fraud conspiracy.
A jury convicted Akebia's former director of biostatistics of securities fraud and conspiracy to commit securities fraud. During the sentencing phase, the government, on behalf of Akebia, sought reimbursement of $312,899 pursuant to the Mandatory Victims Restitution Act, 18 U.S.C. 3663A. The requested reimbursement was for fees Akebia paid to attorneys it hired for assistance while Akebia responded to requests for information during the government's investigation into suspected insider trading activities. The district court awarded Akebia approximately half of the attorneys' fees it requested. The First Circuit affirmed the restitution award, holding that the district court did not improperly exercise its discretion in applying the relevant law and did not abuse its discretion in its award of restitution to Akebia.
The court issued a subsequent related opinion or order on November 24, 2020.